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The identity of the vesicle neurotransmitter transporter expressed by a neuron
largely corresponds with the primary neurotransmitter that cell releases. However,
the vesicular glutamate transporter subtype 3 (VGLUT3) is mainly expressed in non-
glutamatergic neurons, including cholinergic, serotonergic, or GABAergic neurons.
Though a functional role for glutamate release from these non-glutamatergic neurons
has been demonstrated, the interplay between VGLUT3 and the neuron’s characteristic
neurotransmitter transporter, particularly in the case of GABAergic neurons, at the
synaptic and vesicular level is less clear. In this study, we explore how exogenous
expression of VGLUT3 in striatal GABAergic neurons affects the packaging and release
of glutamate and GABA in synaptic vesicles (SVs). We found that VGLUT3 expression
in isolated, autaptic GABAergic neurons leads to action potential evoked release of
glutamate. Under these conditions, glutamate and GABA could be packaged together in
single vesicles release either spontaneously or asynchronously. However, the presence
of glutamate in GABAergic vesicles did not affect uptake of GABA itself, suggesting a
lack of synergy in vesicle filling for these transmitters. Finally, we found postsynaptic
detection of glutamate released from GABAergic terminals difficult when bona fide
glutamatergic synapses were present, suggesting that co-released glutamate cannot
induce postsynaptic glutamate receptor clustering.
Keywords: co-release, vesicular transporter, synaptic transmission, synergy, VGLUT
Introduction
In synaptic transmission, postsynaptic responses are determined in large part by the identity
of the neurotransmitter released at the presynaptic terminal, which is, in turn, determined
by the type of vesicular neurotransmitter transporter expressed by the presynaptic neuron.
The vesicular glutamate transporter 3 (VGLUT3) is expressed mainly in neurons that do not
release glutamate as a primary transmitter, such as cholinergic, serotoninergic, or GABAergic
neurons (Fremeau et al., 2002; Gras et al., 2002; Schäfer et al., 2002; Takamori et al., 2002).
In cholinergic and serotonergic terminals, VGLUT3 stimulates the vesicular uptake of
acetylcholine (Ach; Gras et al., 2008; Nelson et al., 2014) and serotonin (5-HT; Amilhon
et al., 2010), respectively, to synaptic vesicles (SVs). This is likely because the co-packaging
of glutamate, a negatively charged molecule, causes an increase in the pH gradient across the
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vesicular membrane, which then synergistically increases the
driving force for uptake of the other neurotransmitters (Hnasko
et al., 2010; El Mestikawy et al., 2011). However, the vesicular
GABA transporter (VGAT) is thought to rely less on the
pH gradient than the transmembrane electrical potential (Hell
et al., 1990), which would not be enhanced by co-packaging of
glutamate. Nevertheless, transport assays suggest evidence for
synergistic effects for the uptake of GABA by glutamate (Zander
et al., 2010), but these effects have not been investigated in SVs
release from individual terminals.
In addition to potential synergistic roles for glutamate in
loading of GABA into SVs, there is also the question of whether
glutamate may play a functional role in postsynaptic signaling
at a GABAergic synapse. It has been suggested that co-release
of glutamate from GABAergic synapses contributes to tonotopic
organization in the mouse auditory brain stem (Noh et al., 2010),
and recently, that GABA/glutamate co-release affects the output
of the lateral habenula, an area implicated in depression (Root
et al., 2014; Shabel et al., 2014).
In synapses expressing both VGLUT and VGAT, are
glutamate and GABA packaged into the same vesicles? There
are hints that this is the case (Zander et al., 2010; Weston et al.,
2011; Beltrán and Gutiérrez, 2012); however, existing studies
have not provided quantitative analysis of the composition of
individual quantal events. In this study we address whether
GABA and glutamate can be stored in and released from
the same vesicle by recording postsynaptic events in autaptic
GABAergic neurons cultured from the striatum (Bekkers and
Stevens, 1991) exogenously expressing VGLUT3. We found that
action potentials in GABAergic neurons expressing VGLUT3
evoked mixed Postsynaptic currents (PSCs) mediated by both
GABA and glutamate release. Analysis of the spontaneously
released miniature PSC (mPSC) and asynchronous event kinetics
suggest that the quantal events underlying the evoked mixed
PSC included vesicles containing both glutamate and GABA;
however, no change in the amount of GABA packaged into
vesicles with or without VGLUT3 arguing against synergy
for loading between these two neurotransmitters. Interestingly,
glutamate co-released with GABA from GABAergic terminals
was difficult to detect in cultures that contained bona fide
glutamatergic synapses, likely because AMPA receptors in this
case are sequestered away from the GABAergic postsynaptic
sites. This indicates that, at least in GABAergic synapses
exogenously expressing VGLUT3, glutamate release alone is
not sufficient to cause clustering of postsynaptic AMPA
receptors.
Materials and Methods
Neuronal Culture
All experiments involving animals were performed according to
the regulations of the Animal Welfare Committee of the Charité
Universitätsmedizin and the Berlin state government (permit #
T0220/09).
Autaptic neuronal cultures were carried out as described
previously (Xue et al., 2007). Briefly, WT C57/BL6N mice
were sacrificed at P0–2. Brains were dissected out and
placed in 4◦C cooled HBSS. Hippocampus or striatum,
respectively, were removed and incubated in a papain-
containing solution to dissociate the cells. After 45 min
the reaction was stopped by gently exchanging the solution
to an inactivating solution containing 2.5 mg albumin/ml
and 2.5 mg/ml trypsin-inhibitor (Sigma-Aldrich, Germany)
in 5% fetal calf serum (FCS). After 5 min the medium
was replaced by neuronal growth medium (neuronal basal
A (NBA), supplemented with B27, Glutamax (Gibco Life
Technologies, Germany), and penicillin/streptavidin (Roche,
Germany)) and the cells were counted in a Neubauer counting
chamber. For neuronal autaptic cultures 2,500 hippocampal
or 3,000 striatal neurons were seeded onto astrocyte-layered
microislands grown on 30 mm diameter coverslips. For
mass cultures, 50,000 neurons were seeded per well on
astrocyte-layered 12-well (22 mm diameter) plates. Neurons
were grown for 9–16 days in vitro (DIVs) at 37◦C in
5% CO2.
Lentivirus Constructs and Production
Sequence of murine VGLUT3 was cloned into a lentiviral shuttle
vector under the control of a human synapsin-1 promoter. To
enable identification of infected cells the expression cassette of
the protein was fused to a nuclear localization sequence-tagged
green fluorescent protein (NLS-GFP) via a self-cleaving P2A
peptide (Kim et al., 2011).
Lentiviral particles were prepared as described in Lois et al.
(2002). HEK293T cells were cotransfected with 10 µg shuttle
vector and the helper plasmids pCMVdR8.9 and pVSV.G (5 µg
each) with X-tremeGENE 9 DNA transfection reagent (Roche
Diagnostic, Germany). After 72 h the virus-containing cell
culture supernatant was collected and purified by filtration.
Aliquots were flash-frozen in liquid nitrogen and stored at
−80◦C. Virus efficiency was determined by titration with
mice WT hippocampal mass-cultured neurons. For infection,
about 1 × 106 infectious particles were pipetted onto 1 DIV
hippocampal neurons per 35 mm diameter well.
Electrophysiology
Whole-cell patch clamp recordings were performed betweenDIV
9 and 16. The experiments were carried out at room temperature
in an extracellular solution (ECS) containing the following
(in mM): 140 NaCl, 2.4 KCl, 10 HEPES (Merck, Darmstadt,
Germany), 10 glucose (Carl Roth, Karlsruhe, Germany), 2 CaCl2,
(Sigma-Aldrich, St. Louis, USA), 4 MgCl2 (Carl Roth, Karlsruhe,
Germany); 300 mOsm; pH 7.4. To block glutamatergic or
GABAergic responses 10 µM 2, 3-Dioxo-6-nitro-1, 2, 3, 4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris
Bioscience, Bristol, UK) and 30 µM bicuculline (Bic; Tocris
Bioscience, Bristol, UK), respectively, were added to the ECS.
Internal solution contained the following (in mM): 136 KCl, 17.8
HEPES, 1 EGTA (Carl Roth, Karlsruhe, Germany), 4.6 MgCl2,
4 Na2ATP, 0.3 Na2GTP (Sigma-Aldrich, St. Louis, USA), 12
creatine phosphate (Calbiochem, Darmstadt, Germany), and 50
U/ml phosphocreatine kinase (Sigma-Aldrich, St. Louis, USA);
300 mOsm; pH 7.4.
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Borosilicate glass pipettes (Science Products, Hofheim,
Germany) had a resistance of 2–3.5 MΩ. All recordings were
performed with a Multiclamp 700B amplifier and a Digidata
1440A digitizer under control of Clampex 10.0 (Molecular
Devices, Sunnyvale, USA). Data was acquired at 10 kHz and
filtered at 3 kHz. In most of the experiments, membrane
capacitance and 70% of the series resistance were compensated
while changes in series resistance were monitored frequently
throughout the experiments. Only cells with a series resistance
<10 MΩ were used for analysis. PSCs were elicited by a 2 ms
somatic depolarization from −70 mV to 0 mV, which resulted
in an unclamped action potential. Response amplitudes were
measured from baseline. Quantal PSC (qPSC) were recorded as
either spontaneously released events (miniature) or evoked in
an ECS in which CaCl2 was replaced by SrCl2 (asynchronous).
In both cases, GABAergic and glutamatergic components were
pharmacologically isolated with NBQX or Bic, respectively. In
order to optimize detection condition of the mPSCs, and because
voltage escape poses less of a problem for single vesicle events,
series resistance was uncompensated for analysis of mPSCs
decay analysis (Figure 3). For analysis of asynchronous PSCs
evoked in SrCl2 (Figure 4) series resistance was compensated
to assure voltage control during the evoked component of the
response.
Analysis and Statistics
For analysis of qPSCs, events were detected from 1 kHz filtered
traces by running a template-based detection algorithm in
AxoGraph X 1.5.4 (AxoGraph, Berkeley, USA). To analyze
the decay kinetics of quantal events for the co-release
experiments we used two different methods, both resulting
in a similar outcome: (1) After running the recognition
template in AxoGraph the decays of detected mPSCs were
fitted in AxoGraph with a single or double exponential
using a simplex optimization procedure from the peak until
the decay reached baseline. The fits were judged by eye
and single exponential fits were discarded when clearly not
representing the signal; and (2) Individual traces (from
peak to baseline) were fitted in GraphPad Prism using a
Levenberg-Marquardt algorithm and the software ran an
F test to determine if a single or a double exponential
was preferential. The decay time constants for each of
the double exponential fits were converted to a weighted
decay to compare to the single exponential decay time
constant.
Gaussian fits of the decay distributions were performed in
GraphPad Prism. The software ran an F test to determine if the
data was fitted better by a single Gaussian or the sum of multiple
Gaussians.
Comparison of means was performed in GraphPad
Prism. After testing for normality with D’Agostino-
Pearson normality test, the means of two groups were
compared using the Student’s t-test or Mann-Whitney test
(for non-parametric data). Three or more groups were
compared using one-way ANOVA, followed by a Dunnett
test.
Results
VGLUT3 Expression Induces Mixed
GABA/Glutamate Evoked PSC in GABAergic
Autapses
To test whether expression of a glutamate transporter was
sufficient to elicit GABA/glutamate co-release from a GABAergic
neuron, we expressed VGLUT3 in autaptic cultures (Bekkers
and Stevens, 1991) from striatum using a lentiviral expression
system. Whole-cell patch clamp recordings showed reliable
PSCs upon depolarization stimulus (Figure 1). Addition of
the GABA receptor antagonist Bic to the ECS revealed a fast
excitatory component (Figures 1A,C) that could be blocked
by the AMPA receptor antagonist NBQX, which suggests that
glutamate could be released from these GABAergic terminals.
As expected, in autaptic striatal GABAergic neurons expressing
only GFP, but no VGLUT3, PSC responses were blocked
by application of Bic, leaving no NBQX-sensitive component
(Figures 1B,C). On average, the NBQX-sensitive component was
FIGURE 1 | VGLUT3 expression promotes glutamate release in
GABAergic neurons. (A) Exemplary traces of current responses to an
unclamped AP of a striatal GABAergic neuron exogenously expressing
VGLUT3 in control extracellular solution (ECS; black), the AMPA receptor
antagonist, NBQX (blue), the GABAA receptor antagonist, bicuculline (Bic;
red), or both antagonists combined (green). (B) Example traces in the same
conditions as (A) from a striatal GABAergic neuron expressing only GFP.
Stimulations are indicated by an open square; stimulation artifacts and action
potentials have been blanked for illustrative purposes. (C) Plot of mean
amplitudes of evoked response in VGLUT3-expressing cells (left; n = 13) and
control cells expressing GFP (right; n = 6) in presence of NBQX, Bic or no drug
(control). Significance was assessed by comparing responses in control
conditions to each pharmacological treatment using an ANOVA repeated
measures with Dunnett’s multiple comparison tests. Error bars = SEM. ∗∗p ≤
0.01. ∗∗∗p ≤ 0.001. (D) Plot of mean paired-pulse ratio (PPR) in the presence
of NBQX for expressing VGLUT3 or GFP only. Significance was assessed by
Mann-Whitney test. Error bars = SEM.
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FIGURE 2 | AMPA receptor-mediated currents are unaltered in
co-releasing neurons. (A) Exemplary traces of Postsynaptic currents (PSCs)
from striatal GABAergic neurons expressing VGLUT3 (black) or GFP (red) in
the presence of Bic. (B) Responses to kainate (10 µM) application in the
neurons from (A). (C) Plot of average PSC (PSC) amplitude in presence of Bic.
∗∗∗p < 0.0001. (D) Plot of average kainate steady-state current. Number of
cells indicated in graphs. Error bars = SEM.
significantly higher when cells exogenously expressed VGLUT3
(Bic minus Bic + NBQX: VGLUT3 2.43 ± 0.54 nA, n = 13;
GFP 0.09 ± 0.14 nA, n = 6; ∗∗p = 0.0018, Mann-Whitney
test).
We next examined whether paired-pulse behavior in the
GABAergic synapses was altered by the expression of VGLUT3.
We found that on average the paired-pulse ratio (PPR), as
assessed by the amplitude of a second stimulation evoked PSC
divided by that of the first with an interpulse interval of 100 ms,
of the purely GABAergic response was not different between
cells that expressed VGLUT3 and those that did not (Figure 1D;
p = 0.314, Mann-Whitney test). This suggests that co-release of
glutamate from GABAergic neurons does not affect presynaptic
release probability.
Glutamate Release from GABAergic Autaptic
Neurons does not Change AMPAR Expression
As striatal GABAergic neurons expressing VGLUT3 showed
an evoked glutamate-mediated response, we next wondered
whether glutamate release changed the expression of AMPA-type
glutamate receptors on these cells. To test this, we compared
the current evoked by application of kainate (10 µM) to striatal
cells expressing VGLUT3 + GFP or GFP alone (Figure 2B).
We found that kainate evoked a response in all cells, whether
they expressed VGLUT3 or not (Figures 2B,D; p = 0.290,
Student’s t-test); however, only cells expressing VGLUT3 had a
glutamatergic synaptic response in the presence of Bic (30 µM;
Figures 2A,C; p < 0.0001, Mann-Whitney test). Together, these
data suggest that AMPA receptor expression on GABAergic
autaptic neurons from striatum is not altered by co-release of
GABA and glutamate.
Mixed Glutamate/GABA Postsynaptic Responses
Caused by Spontaneous Release in
VGLUT3-Expressing Striatal Neurons
Spontaneous release of single vesicles is an ideal system
to study if glutamate and GABA are stored in distinct
vesicle pools or if they are stored in the same vesicles.
We recorded miniature postsynaptic events (mPSCs) from
VGLUT3-expressing, autaptic, striatal neurons in control ECS
without antagonists and in the presence of NBQX or Bic to isolate
a GABAergic or glutamatergic component of the response,
respectively (Figures 3A–C). Similar to our results with evoked
release we observed fast-decaying events in the presence of
Bic (Figure 3C) and slower-decaying events in the presence of
NBQX (Figure 3B). To determine whether the events in the
control solution simply represent the sum of the events in NBQX
and Bic or if there is also a population of mixed events, we
pooled the events from each condition and analyzed the decay
times. We found that distributions for all of these populations
were significantly different (p < 0.0001 for all combinations;
Kolmogorov-Smirnov test). The frequency histograms for events
recorded in Bic or NBQX were best fitted with a single Gaussian
(Figure 3D; Bic: mean tau ± SD, 2.6 ± 1.3 ms, R2 = 0.96;
NBQX: mean tau± SD, 18.5± 8.7 ms, R2 = 0.68). The frequency
histogram for events recorded in control solution was best fitted
by the sum of three Gaussians (mean tau1 ± SD1, 3.5 ± 1.0 ms,
mean tau2 ± SD2, 10.2 ± 2.8 ms, mean tau3 ± SD3, 17.8 ±
10.3 ms R2 = 0.86).
To confirm that these events recorded in the control
conditions actually contained a population of mixed glutamate-
GABA events, we compared the cumulative frequency
distribution of the control events to an artificial population
consisting of a combination of events recorded in Bic or NBQX
(Figure 3E). We found that the distribution of these two
populations was significantly different (p < 0.0001, Kolmogorov-
Smirnov test; Figure 3E), suggesting that a significant portion
of spontaneous events recorded from VGLUT3-expressing
GABAergic neurons reflect co-release of glutamate and GABA
from the same synaptic vesicle.
We next tested whether co-packaging of glutamate and GABA
leads to an increase in GABA content in single vesicles. This
synergistic effect was found in other dual-transmitter systems
(Amilhon et al., 2010; Hnasko et al., 2010). We compared
the GABA content of minis by measuring spontaneous event
amplitudes in the presence of NBQX. Striatal interneurons
expressing VGLUT3 did not show altered mini amplitudes
compared to control interneurons expressing GFP (Figure 3F).
Thus, the presence of glutamate in those vesicles does not seem
to have a synergistic effect on GABA uptake.
Glutamate and GABA Containing Vesicles are
Released by AP Stimulation
For many years, it has been debated whether spontaneous
or stimulus-evoked neurotransmitter release modes utilize
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FIGURE 3 | Glutamate and GABA are released from the same vesicles but do not synergize. Exemplary traces of spontaneous release in striatal autaptic
neurons expressing VGLUT3 under three recording conditions: in control ECS (A), ECS with NBQX (B) and ECS with Bic (C). (D) Histogram of decay times (tau) of
spontaneous events under the conditions described in (A–C) from 8 neurons. The plots were fitted with single Gaussian (NBQX and Bic; red and blue lines) or with
the sum of three Gaussians (control; black line), respectively. (E) Cumulative frequency plot of decay times from histogram in (D). Values from “NBQX group” and “Bic
group” were combined to create the “combined group”. (F) Comparison of mPSC amplitudes in presence of NBQX. Circles represent individual cells. Horizontal lines
show mean ± SEM.
vesicles from the same pool (Sara et al., 2005; Groemer and
Klingauf, 2007). Therefore, we wanted to test whether, in
addition to spontaneously released vesicles containing both
GABA and glutamate in the VGLUT3-expressing GABAergic
neurons (Figure 3), vesicles released by stimulation could
also contain both transmitters. To address this, we recorded
from VGLUT3-expressing cultured, autaptic striatal neurons. To
study the content of single, evoked vesicles, we replaced the
extracellular Ca2+ with Sr2+ (1 mM), and pharmacologically
dissected the responses under these conditions (Figure 4). As
expected (Goda and Stevens, 1994), the addition of [Sr2+]e
produced asynchronous events, including putative qPSC events
(Figures 4A–C). We examined the neurotransmitter content of
these quantal events (single peak events that occurred within
one spost-stimulus) in control ECS, with the addition of NBQX
or Bic (Figures 4A–C), and pooled the asynchronous events
from eleven cells, which were both GFP positive and displayed
detectable events in the presence of Bic. When all events were
pooled from each condition, we found that distributions for
each of these populations were significantly different (p < 0.0001
for all combinations; Kolmogorov-Smirnov test). The frequency
histograms for events recorded in Bic or NBQX were best fitted
with a single Gaussian (Figure 4D; Bic: mean tau ± SD, 2.2 ±
0.9ms, R2 = 0.97; NBQX:mean tau± SD, 12.9± 9ms, R2 = 0.77).
The frequency histogram for events recorded in control ECS
was best fitted by the sum of two Gaussians, where the mean
amplitude of each Gaussian peak was shifted to the right or left
of the Bic or NBQX isolated events, respectively (mean tau1 ±
SD1, 3.9 ± 2 ms, mean tau2 ± SD2, 11.4 ± 7.2 ms, R2 = 0.87).
To confirm that the events recorded in the control extracellular
conditions contained a population of mixed glutamate-GABA
events, we compared the cumulative frequency distribution of
the control events to an artificial population consisting of a
combination of events recorded in Bic or NBQX (Figure 4E).
We found that the distribution of these two populations was
significantly different (p < 0.0001, Kolmogorov-Smirnov test;
Figure 4E), suggesting that a portion of asynchronous events
recorded from VGLUT3-expressing GABAergic neurons reflect
co-release of glutamate and GABA from the same synaptic
vesicle. It should be noted that the decay times for GABA
only and glutamate/GABA mixed asynchronous qPSCs were
faster than those reported for mPSCs. This is likely because
the strontium recordings were performed with series resistance
compensation (see Section ‘‘Materials and Methods’’).
Glutamate/GABA Co-Release in a Developing
Circuit
Our findings show that glutamate can be both released and
detected at GABAergic synapses from autapses expressing
VGLUT3. However, in neural circuits in the brain, GABAergic
synapses co-releasing glutamate must exist on the same
postsynaptic target cells as bona fide glutamatergic synapses.
Therefore, we examined whether we could still detect glutamate
released from GABAergic striatal neurons expressing VGLUT3
when they were cultured in the presence of glutamatergic
neurons from hippocampus. We performed paired whole cells
recordings from mixed cultures of striatal and hippocampal
neurons infected with VGLUT3, and pharmacologically isolated
the PSCs as previously described (Figures 1, 3–4). On average,
the responses from VGLUT3-expressing GABAergic presynaptic
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FIGURE 4 | Glutamate and GABA are released from the same vesicles
during evoked asynchronous release. Exemplary traces of Sr2+-evoked
asynchronous release in striatal autaptic neurons expressing VGLUT3 under
three recording conditions: in control ECS (A) ECS with NBQX (B) and ECS
with Bic (C). (D) Histogram of decay times (tau) of quantal events under the
conditions described in (A–C). Events were pooled from 11 cells. The plots
were fitted with single Gaussian (NBQX and Bic; red and blue lines) or with the
sum of two Gaussians (control; black line), respectively. (E) Cumulative
frequency plot of decay times. Values from “NBQX group” and “Bic group”
were combined to create the “combined group”.
neurons were almost completely blocked by application of
Bic, indicating that glutamatergic co-release could not be
detected. To test whether the lack of detection of glutamate
co-release from GABAergic neurons was due to a low
expression level of VGLUT3 in mixed striatal/hippocampal
cultures, we performed sister-culture experiments with pure
striatal neurons or mixed striatal/hippocampal neurons plated
on astrocyte microislands, and again recorded from autaptic
striatal neurons expressing VGLUT3 or from paired neurons
in multi-cell microisland circuits. We found, again, that the
majority of autaptic GABAergic neurons expressing VGLUT3
had an NBQX-sensitive component of their evoked release
(Figure 5A). On the other hand, the PSCs detected in
paired recordings from multi-cell microislands where striatal
GABAergic neurons expressing VGLUT3 were co-cultured with
hippocampal neurons were almost entirely blocked by Bic
application. Plotting the total amplitude of each cell against its
amplitude in the presence of Bic (‘‘glutamatergic component’’)
demonstrates the influence of the culturing system on the size
of the glutamatergic component compared to the influence of
the total response size (Figure 5B). While this could indicate
that VGLUT3 is actively excluded from GABAergic vesicles
in mixed cultures, a more likely explanation could be that
even though glutamate is co-released from GABAergic terminals
expressing VGLUT3, the detection could be limited by the
FIGURE 5 | Amount of detectable glutamate co-release varies between
different culture systems. (A) Plot of PSC amplitudes in GABAergic striatal
neurons expressing VGLUT3. Recordings in three different culture systems:
mass culture (red), autaptic culture (black/gray) and 2 or more cells on an
astrocyte feeder island (blue). Depicted are the PSC sizes in control ECS
(darker colors) and the glutamatergic component in the presence of Bic
(lighter colors). Each data point represents a cell. Horizontal lines show the
average response size. (B) Plot of PSC amplitude in ECS (“total amplitude”)
against amplitude in Bic (“amplitude glu component”) of the same cell
compared over the three different culture systems.
availability of postsynaptic AMPA receptors, which may be
sequestered by bona fide glutamatergic synapses in a network
environment.
Discussion
Co-release of two or more classical neurotransmitters from the
same neuron is now considered to be a common principle
throughout the nervous system (Whittaker et al., 1972; Jonas
et al., 1998; Higley et al., 2011; Beltrán and Gutiérrez, 2012).
We studied the co-release of glutamate and GABA in striatal
interneurons, which exogenously expressed VGLUT3, and
present the following findings: (1) Striatal GABAergic SVs do
not have active mechanisms to exclude vesicular glutamate
transporters and the presence of VGLUT on these vesicles
is enough to induce glutamate co-release; (2) Glutamate and
GABA are at least partially stored in the same vesicles and
these vesicles are involved in both spontaneous and evoked
(asynchronous) release; (3) Co-storage of glutamate and GABA
does not result in neurotransmitter synergy as GABA content is
unaltered in VGLUT3-expressing vesicles; and (4) In a network
of glutamatergic and GABAergic neurons co-release of glutamate
Frontiers in Synaptic Neuroscience | www.frontiersin.org 6 September 2015 | Volume 7 | Article 16
Zimmermann et al. Glutamate/GABA co-release from single vesicles
is not sufficient to induce clustering of AMPA receptors at the
GABAergic postsynaptic structure.
Pharmacological dissection of evoked PSCs from GABAergic
neurons expressing the VGLUT3 transporter has shown that
these responses contain both a glutamatergic and GABAergic
component (Figure 1; Weston et al., 2011). However, these
measurements cannot discern between glutamate and GABA
released from the same or separate synapses or vesicles.
Therefore, to further investigate this question, we took
advantage of the distinct kinetics of postsynaptic responses
mediated by GABAA and AMPA receptors (Figure 3). We
found that a portion of spontaneously released mPSCs in
striatal autapses expressing VGLUT3 showed a postsynaptic
response, the decay of which was a convolution of the kinetics
of GABAA and AMPA receptor responses, suggesting that
glutamate and GABA are released from the same vesicle.
Importantly, we could also show that co-release of glutamate
and GABA can occur in response to presynaptic stimulation,
as asynchronous PSC evoked in the presence of SrCl2 also
contained a population with mixed GABAA and AMPA
receptor kinetics (Figure 4). It should be noted that the
percentage of mixed events detected from the total population
of spontaneous or asynchronous events does not represent the
fraction of vesicles that contain glutamate and GABA per se
as the composition of postsynaptic receptors is unlikely to be
uniform.
Does the co-storage of glutamate in GABAergic vesicles
have synergistic effects on filling? Our findings and a recent
study by Case et al. (2014), indicate that GABA content is
not influenced by co-packaging of glutamate (but see Zander
et al., 2010). A series of studies show that the presence of
VGLUT3 in cholinergic and serotonergic terminals stimulated
the uptake of ACh and serotonin (5-HT) to SVs (Gras et al.,
2008; Amilhon et al., 2010). These so called ‘‘synergistic effects’’
have been attributed to an increase in the pH gradient (1pH)
across the vesicle membrane due to the presence of glutamate,
which then drives neurotransmitter uptake (Hnasko et al., 2010;
El Mestikawy et al., 2011). However, neurotransmitter transport
by the vesicular acetylcholine transporter (VAChT) and the
vesicular monoamine transporter (VMAT2) into SVs depends
largely on 1pH (Johnson et al., 1981; Nguyen et al., 1998).
Because accumulation of GABA by VGAT depends both on the
transmembrane potential (1ψ) and on 1pH (Hell et al., 1990),
the acidification of SVs by VGLUTs seems to be less important
than in the case of the positively-charged ACh, dopamine and
5-HT.
Even though multiple cell types in the brain have been
identified where vesicular GABA and glutamate transporters are
co-expressed, it has been difficult to prove co-release of GABA
and glutamate at those synapses. Co-release of the two fast-acting
NTs has been shown in the lateral superior olive (LSO; Gillespie
et al., 2005) and in hippocampal mossy fibers (Gutiérrez, 2003;
Beltrán and Gutiérrez, 2012). GABA/glycinergic synapses from
the medial nucleus of the trapezoid body (MNTB) express
VGLUT3 and co-release glutamate, which is important for
the refinement of an inhibitory map in the auditory system
(Noh et al., 2010). It has also been shown that glutamatergic
granule cells in the dentate gyrus transiently release GABA
during development from single mossy fiber giant boutons in
hippocampal brain slice (Beltrán and Gutiérrez, 2012; Münster-
Wandowski et al., 2013) and in autaptic culture (Valente et al.,
2015).
One important question from a cell biological standpoint
is whether co-release of glutamate at a GABAergic synapse
influences the postsynaptic receptor identity. We found that in
isolated, autaptic GABAergic neurons cultured from striatum,
expression of VGLUT3 induced co-release of glutamate
detected postsynaptically at the same synapses as GABA
(Figures 3–4). This suggests that GABAergic synapses in
the autaptic model contain AMPA receptors. Interestingly, it
has been shown that GABAergic neurons grown in isolation
have a diffuse distribution of AMPA receptors throughout
their dendrites; however, in the presence of glutamatergic
input, AMPA receptor distribution becomes punctate (Rao
et al., 2000). We found that in the presence of glutamatergic
input in mass culture or multicellular microislands, co-
release of glutamate from GABAergic terminals was no
longer detectable through AMPA receptor-mediated currents
(Figure 5). Because our experiments comparing co-release in
isolated, GABAergic striatal neurons and GABAergic striatal
neurons in mixed mass culture used sister cultures expressing
VGLUT3 from the same constructs, we speculate that the
lack of AMPA receptor-mediated currents in only the mass
culture model is not due to lack of VGLUT3 expression
in these cells. Instead, we favor the interpretation that
with glutamatergic input, AMPA receptors are recruited to
glutamatergic synapses, and that co-release of glutamate from
a GABAergic terminal is not sufficient to induce AMPA
receptor clustering at its postsynaptic element. However, it
cannot be ruled out that at GABAergic synapses endogenously
co-expressing VGLUT3, that the postsynaptic element may
contain specific molecules promoting the capture of AMPA
receptors.
We have shown, as a proof of principle, that on a
quantal level, expression of both VGLUT and VGAT in
a presynaptic terminal leads to glutamate/GABA co-release.
How might this co-release influence signaling at VGLUT3-
expressing GABAergic terminals? It is feasible that co-released
glutamate could act through a spillover mechanism to activate
metabotropic glutamate receptors (mGluRs), which are present
on GABAergic terminals (Somogyi et al., 2003). Another distinct
possibility is that glutamate may activate high-affinity NMDA
receptors, which have been suggested to exist at VGLUT3-
expressing GABAergic terminals in adult rat hippocampus
(Stensrud et al., 2015). In addition, activation of NMDA
receptors by co-released glutamate has been proposed as the
mechanism by which expression of VGLUT3 in GABAergic
synapses refines the tontopic map in auditory brainstem
(Gillespie et al., 2005; Noh et al., 2010). Further details
regarding how glutamate co-release at GABAergic terminals in
various regions with endogenous VGLUT3 expression affects
signaling at the synaptic level and function at the circuit
level are interesting questions to be addressed by further
studies.
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